← USPTO Patent Grants

Sodium oxybate to treat idiopathic hypersomnia

Grant US12582622B2 Kind: B2 Mar 24, 2026

Assignee

JAZZ PHARMACEUTICALS IRELAND LIMITED

Inventors

Franck Skobieranda, Dan Chen, Amanda Leigh Sterkel

Abstract

The present disclosure relates to methods of treating idiopathic hypersomnia with oxybate, preferably sodium oxybate.

CPC Classifications

A61K 31/19 A61P 25/20 A61P 25/00

Filing Date

2021-10-08

Application No.

18248499

Claims

29